Discontinued — last reported Q3 '22
Medical — Impairment of Intangible Assets (Excluding Goodwill)
Becton, Dickinson and Company Medical — Impairment of Intangible Assets (Excluding Goodwill) remained flat by 0.0% to $13.50M in Q3 2022 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase signals potential issues with the viability of specific product lines or acquired technologies, while a zero or low value suggests stable asset valuations.
Detailed definition
This metric measures the non-cash charge recognized when the carrying value of identifiable intangible assets, such as p...
Peer comparison
Comparable to 'Impairment of Intangible Assets' or 'Write-downs of Intangibles' found in the notes to financial statements of peer life sciences and medical device companies.
bdx_segment_medical_impairment_of_intangible_assets_excluding_goodwillHistorical Data
| FY'22 | |
|---|---|
| Value | $54.00M |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Becton, Dickinson and Company's medical — impairment of intangible assets (excluding goodwill)?
- Becton, Dickinson and Company (BDX) reported medical — impairment of intangible assets (excluding goodwill) of $13.50M in Q3 2022.
- What does medical — impairment of intangible assets (excluding goodwill) mean?
- The reduction in the recorded value of non-goodwill intangible assets due to a decline in their expected future value.